Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$3.27M Sell
149,613
-5,101
-3% -$109K ﹤0.01% 1549
2023
Q4
$3.6M Buy
154,714
+3,490
+2% +$70.2K ﹤0.01% 1528
2023
Q3
$2.98M Sell
151,224
-2,890
-2% -$56.9K ﹤0.01% 1583
2023
Q2
$3.49M Sell
154,114
-15,613
-9% -$314K ﹤0.01% 1570
2023
Q1
$3.33M Buy
169,727
+66,460
+64% +$1.28M ﹤0.01% 1568
2022
Q4
$1.78M Buy
+103,267
New +$1.83M ﹤0.01% 1952

Other funds holding RXO

Credit Suisse's RXO Position: Q1 2024 in Review

Credit Suisse reduced its RXO (RXO) stake by 3.3% in Q1 2024, selling an estimated $109K and leaving 149,613 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Credit Suisse first reported a position in RXO in Q4 2022 and has held it in 6 quarters since. The position peaked at $3.6M in Q4 2023. 241 funds tracked by Wall St. Rank hold RXO as of Q1 2024.

  • Credit Suisse held 149,613 shares of RXO worth $3.27M as of Q1 2024.
  • Credit Suisse sold 5,101 RXO shares in Q1 2024, an estimated $109K.
  • RXO made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1549 holding.
  • Credit Suisse first reported a position in RXO in Q4 2022 and has held it in 6 quarters since.
  • Credit Suisse's RXO position peaked at $3.6M in Q4 2023.
  • 241 funds tracked by Wall St. Rank held RXO as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.